| Product Code: ETC13179260 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neglected Tropical Disease Market was valued at USD 3.7 Billion in 2024 and is expected to reach USD 5.3 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Neglected Tropical Disease (NTD) Market is characterized by a focus on diseases that primarily affect populations in low-income countries, often with limited resources for healthcare. These diseases, such as malaria, dengue fever, Chagas disease, and leishmaniasis, have historically received less attention and funding compared to other global health issues. However, in recent years, there has been a growing recognition of the burden these diseases impose on affected populations and the need for innovative solutions. The market for NTD treatments and interventions is driven by a combination of government funding, philanthropic initiatives, and partnerships between pharmaceutical companies, non-profit organizations, and research institutions. Efforts to improve access to affordable treatments, develop new drugs and vaccines, and strengthen healthcare systems in endemic regions are key priorities in addressing the Global Neglected Tropical Disease Market.
The Global Neglected Tropical Disease (NTD) market is experiencing significant growth driven by increased awareness, government initiatives, and collaborations among pharmaceutical companies and non-profit organizations. Key trends include the development of innovative treatment solutions, expansion of access to healthcare in low- and middle-income countries, and rising investments in research and development. Opportunities in the market include the potential for partnerships to enhance distribution networks, the growing focus on preventive measures, and the increasing demand for cost-effective and sustainable solutions. With a shift towards achieving global health equity, the NTD market offers promising prospects for companies to address unmet medical needs, improve patient outcomes, and make a positive impact on public health worldwide.
The Global Neglected Tropical Disease Market faces various challenges including lack of awareness and funding, limited access to healthcare in remote areas where these diseases are prevalent, and the high cost of developing and distributing treatments. Additionally, the complex nature of these diseases, which often require multifaceted approaches for effective treatment, poses a challenge for researchers and healthcare providers. Furthermore, regulatory hurdles and limited market incentives for pharmaceutical companies to invest in research and development for these diseases contribute to the challenges faced by the market. Overall, addressing these challenges requires a concerted effort from governments, non-profit organizations, and the private sector to prioritize funding, research, and access to healthcare services in order to effectively combat neglected tropical diseases on a global scale.
The Global Neglected Tropical Disease (NTD) market is primarily driven by increasing awareness and initiatives aimed at controlling and eliminating NTDs, as well as the growing focus on public health programs in developing countries. The availability of funding from government organizations, non-profit entities, and international agencies for research and development of treatments for NTDs is also a key driver. Moreover, partnerships between pharmaceutical companies, research institutions, and government bodies are contributing to the development of new therapies and interventions for NTDs. Additionally, the rising prevalence of NTDs in low-income regions, coupled with efforts to improve healthcare infrastructure and access to medicines, are fueling market growth for treatments targeting neglected tropical diseases.
Government policies related to the Global Neglected Tropical Disease (NTD) Market primarily focus on increasing access to affordable treatments, promoting research and development for new therapies, and enhancing public health infrastructure in affected regions. Many governments have implemented programs to support drug donations, partnerships with pharmaceutical companies, and funding for research initiatives aimed at combating NTDs. Additionally, there is a growing emphasis on strengthening healthcare systems to improve diagnosis, treatment, and prevention of NTDs. Governments are also working towards enhancing collaboration between public and private sectors to address the challenges associated with these diseases. Overall, the policies aim to reduce the burden of NTDs on vulnerable populations and achieve sustainable progress in controlling and eliminating these diseases globally.
The Global Neglected Tropical Disease Market is expected to see steady growth in the coming years, driven by increasing awareness, government initiatives, and partnerships between pharmaceutical companies and non-profit organizations. The market is likely to benefit from advancements in research and development, leading to the introduction of new treatment options and vaccines. With a focus on expanding access to healthcare in developing regions, the market is projected to witness a rise in demand for affordable and effective solutions for neglected tropical diseases. Additionally, collaborations between public and private sectors are anticipated to drive innovation and improve healthcare infrastructure, ultimately contributing to the growth of the Global Neglected Tropical Disease Market.
The global neglected tropical disease market exhibits varying trends across regions. In Asia, the market is driven by high prevalence rates of diseases like dengue, malaria, and lymphatic filariasis, leading to increased government initiatives and funding for control and treatment programs. North America dominates in terms of market share due to advanced healthcare infrastructure and strong R&D activities focused on developing new treatments and vaccines. Europe also holds a significant market share, with a focus on research collaborations and partnerships to address neglected tropical diseases. In the Middle East and Africa, the market growth is hindered by limited access to healthcare services and resources. Latin America is witnessing growth due to increasing awareness and investment in disease control programs, albeit challenges such as political instability and economic constraints impacting market development.
Global Neglected Tropical Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neglected Tropical Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neglected Tropical Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neglected Tropical Disease Market - Industry Life Cycle |
3.4 Global Neglected Tropical Disease Market - Porter's Five Forces |
3.5 Global Neglected Tropical Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neglected Tropical Disease Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Global Neglected Tropical Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Global Neglected Tropical Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neglected Tropical Disease Market Trends |
6 Global Neglected Tropical Disease Market, 2021 - 2031 |
6.1 Global Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neglected Tropical Disease Market, Revenues & Volume, By Dengue, 2021 - 2031 |
6.1.3 Global Neglected Tropical Disease Market, Revenues & Volume, By Rabies, 2021 - 2031 |
6.1.4 Global Neglected Tropical Disease Market, Revenues & Volume, By Trachoma, 2021 - 2031 |
6.1.5 Global Neglected Tropical Disease Market, Revenues & Volume, By Buruli Ulcer, 2021 - 2031 |
6.1.6 Global Neglected Tropical Disease Market, Revenues & Volume, By Yaws, 2021 - 2031 |
6.1.7 Global Neglected Tropical Disease Market, Revenues & Volume, By Leprosy, 2021 - 2031 |
6.1.8 Global Neglected Tropical Disease Market, Revenues & Volume, By Chagas Disease, 2021 - 2031 |
6.1.9 Global Neglected Tropical Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neglected Tropical Disease Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.3 Global Neglected Tropical Disease Market, Revenues & Volume, By Vaccines, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Neglected Tropical Disease Market, Overview & Analysis |
7.1 North America Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.4 North America Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
8 Latin America (LATAM) Neglected Tropical Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
8.4 Latin America (LATAM) Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
9 Asia Neglected Tropical Disease Market, Overview & Analysis |
9.1 Asia Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
9.4 Asia Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
10 Africa Neglected Tropical Disease Market, Overview & Analysis |
10.1 Africa Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
10.4 Africa Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
11 Europe Neglected Tropical Disease Market, Overview & Analysis |
11.1 Europe Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
11.4 Europe Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
12 Middle East Neglected Tropical Disease Market, Overview & Analysis |
12.1 Middle East Neglected Tropical Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neglected Tropical Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neglected Tropical Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neglected Tropical Disease Market, Revenues & Volume, By Disease, 2021 - 2031 |
12.4 Middle East Neglected Tropical Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
13 Global Neglected Tropical Disease Market Key Performance Indicators |
14 Global Neglected Tropical Disease Market - Export/Import By Countries Assessment |
15 Global Neglected Tropical Disease Market - Opportunity Assessment |
15.1 Global Neglected Tropical Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neglected Tropical Disease Market Opportunity Assessment, By Disease, 2021 & 2031F |
15.3 Global Neglected Tropical Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
16 Global Neglected Tropical Disease Market - Competitive Landscape |
16.1 Global Neglected Tropical Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Neglected Tropical Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here